MedTrace Logo

Testing the Efficacy of Mindfulness-based Stress Reduction in the Prevention of Perimenopausal Depression

NCT03526523 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2021-01-06

No results posted yet for this study

Summary

Depression is the leading cause of disability worldwide and a risk factor for other diseases. While women are at elevated risk for depression in general, the menopause transition is a particularly vulnerable time for many women, with the risk for depression increasing 2-4 fold. The objective of this research study is to determine whether mindfulness-based stress reduction (MBSR), an 8-week structured intervention involving meditation and yoga, has any beneficial mood effects for women undergoing this vulnerable time.

Conditions

  • Perimenopausal Depression
  • Depressive Symptoms

Interventions

BEHAVIORAL

Mindfulness-based stress reduction

8 weekly 2.5-hour group sessions of mindfulness based stress reduction, led by a certified MBSR instructor

Sponsors & Collaborators

  • Saskatchewan Health Research Foundation

    collaborator OTHER

  • Saskatchewan Centre for Patient-Oriented Research

    collaborator OTHER

  • University of Calgary

    collaborator OTHER

  • Saskatchewan Health Authority - Regina Area

    collaborator OTHER

  • University of Regina

    lead OTHER

Principal Investigators

  • Jennifer L Gordon, PhD · University of Regina

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
42 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-05
Primary Completion
2020-03-20
Completion
2020-03-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03526523 on ClinicalTrials.gov